April 2011
Worldwide Biotech;Apr2011, Vol. 23 Issue 4, p4
Trade Publication
The article reports the clinical trial application of biopharmaceutical firm Sinovac Biotech Ltd. for its 13-valent pneumococcal conjugate vaccine (PCV) to the State Food and Drug Administration (SFDA) of China. The vaccine regulatory system of the SFDA passed the evaluation of the World Health Organization (WHO), enabling Chinese vaccine products to become available internationally through United Nations (UN) agencies. Sinovac is also developing a pneumococcal polysaccharides vaccine (PPV).


Related Articles

  • Clinic Roundup.  // BioWorld Today;12/29/2010, Vol. 21 Issue 250, p5 

    The article reports that the China State Food and Drug Administration has approved an application by Sinovac Biotech Ltd. to commence clinical trials for its inactivated EV71 vaccine against hand, foot and mouth disease.

  • SINOVAC GETS SFDA APPROVAL TO BEGIN EV71 VACCINE TRIALS.  // Worldwide Biotech;Feb2011, Vol. 23 Issue 2, p5 

    The article reports on an approval received by Sinovac Biotech Ltd. from the China State Food and Drug Administration (SFDA) to begin clinical trials for its proprietary inactivated EV71 vaccine against Hand, Foot and Mouth Disease (HFMD). Majority of HFMD cases happen in children under five...

  • Sinovac: Panflu on track in pandemic flu.  // PharmaWatch: Monthly Review;May2006, Vol. 5 Issue 5, p38 

    The article reports on the completion of Sinovac Biotech Ltd.'s phase I clinical trial of its avian influenza vaccine Panflu on the shot regimen of either the vaccine or placebo. The action represents another step on the product candidate's way to becoming a much-needed addition to global...

  • Sinovac Jumps on Results for Hand, Foot and Mouth Vaccine. Shaffer, Catherine // BioWorld Today;3/15/2013, Vol. 24 Issue 50, p1 

    The article discusses the results of the Phase III data of the double-blind, randomized, placebo-controlled trial of Sinovac Biotech Ltd.'s enterovirus 7I (EV 7I) vaccine which reveal efficacy, immunogenicity and safety against hand, foot and mouth disease (HFMD). The data showed a 95.4 percent...

  • Research Update.  // PharmaWatch: Biotechnology;Oct2007, Vol. 6 Issue 10, p4 

    The article offers news briefs related to medical research. Sinovac Biotech Ltd. started its move to immunize volunteers for pandemic avian influenza vaccine trial. Thallion Pharmaceuticals Inc. has completed its clinical trial with ECO-4601 as part of the phase II extention for cancer drug...

  • Pneumococcal vaccines.  // Weekly Epidemiological Record;6/11/99, Vol. 74 Issue 23, p177 

    Focuses on the recommendation of the vaccines for pneumococcal diseases by the department of vaccines and other biologicals department of the World Health Organization. Presentation of the vaccine in the Expanded Programme on Immunization; Impact of the scheme on public health; Assessment on...

  • Chinese vaccine developers gain WHO imprimatur. Hepeng Jia; Carey, Karen // Nature Biotechnology;Jun2011, Vol. 29 Issue 6, p471 

    The article reports on an announcement by the World Health Organization (WHO) that the State Food and Drug Administration (SFDA) of China complies with the international vaccine regulation standards. This announcement implies that the vaccines from this Asian country have the imprimatur of...

  • THE GLOBAL REPORT.  // Applied Clinical Trials;Sep2007, Vol. 16 Issue 9, p30 

    The article offers world news briefs related to clinical trials industry. The World Trade Organization (WTO) announces that Rwanda intends to override patents and import the antiretroviral Apo-triAvir from Apotex Inc. Cao Wenzhuang, department director of the State Food and Drug Administration...

  • VACCINE REPORT.  // BioPharm International;Feb2008, Vol. 21 Issue 2, p12 

    The article offers news briefs related to vaccine developments. Apitope Technology Ltd. launched ATX-MS-1467, a therapeutic vaccine, which is safe for secondary progressive multiple sclerosis (SPMS) patients. Sinovac Biotech Ltd. conducted a positive clinical trial of pandemic influenza (H5N1)...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics